Abhijit 'Ron' Mazumder brings nearly three decades of experience spanning genomics, biomarkers, and computation, including senior leadership roles in global oncology biomarker development and companion diagnostics at Genentech before transitioning to early-stage venture investing. He designed Illumina Ventures Labs as a global hybrid platform that provides in-kind sequencing reagents and intensive monthly working sessions for up to two years, allowing him to work closely alongside founders through a structured hands-on due diligence process before leading their Series A rounds.